NEXT SCIENCE Co.,Ltd. (KOSE:A003580) agreed to acquire 45.4% stake in Dandi Bioscience Inc. for KRW 6.3 billion on October 5, 2018. As per the terms, NEXT SCIENCE will issue Cash and Round 24 convertible bonds and will acquire 1.3 million shares excluding preferred stock. As of December 31, 2017, Dandi Bioscience Inc. reported total assets of KRW 1.7 billion and net loss of KRW 570 million. Resolution of board of directors was passed on October 5, 2018.

NEXT SCIENCE Co.,Ltd. (KOSE:A003580) cancelled the acquisition of 45.4% stake in Dandi Bioscience Inc. on October 5, 2019.